Zosano Pharma Corporation (ZSAN)
| Market Cap | 62.14M |
| Revenue (ttm) | 922,000 |
| Net Income (ttm) | -31.05M |
| Shares Out | 118.35M |
| EPS (ttm) | -0.29 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,460,015 |
| Open | 0.579 |
| Previous Close | 0.574 |
| Day's Range | 0.519 - 0.590 |
| 52-Week Range | 0.519 - 3.060 |
| Beta | 3.28 |
| Analysts | Buy |
| Price Target | 2.00 (+280.9%) |
| Earnings Date | Nov 12, 2021 |
About ZSAN
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Financial Performance
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for Zosano Pharma stock is "Buy." The 12-month stock price forecast is 2.00, which is an increase of 280.88% from the latest price.
News
Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
FREMONT, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock option...
Today's Hot Penny Stocks: What's Moving ZSAN, AVGR and CEI Higher Wednesday?
Today's hot penny stocks are catching the eyes of investors and we're diving into everything investors need to know about them on Wednesday! The post Today's Hot Penny Stocks: What's Moving ZSAN, AVGR a...
Zosano Pharma Corporation (ZSAN) Reports Q3 Loss, Misses Revenue Estimates
Zosano Pharma Corporation (ZSAN) delivered earnings and revenue surprises of 0.00% and -10.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s...
Zosano Pharma Reports Third Quarter 2021 Financial Results
FREMONT, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended Sept...
Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Phar...
FREMONT, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the company has been granted a Type C written resp...
Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment Conference
FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, S...
Zosano Pharma Corporation (ZSAN) Reports Q2 Loss, Misses Revenue Estimates
Zosano Pharma Corporation (ZSAN) delivered earnings and revenue surprises of 0.00% and -30.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zosano Pharma Reports Second Quarter 2021 Financial Results
FREMONT, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended Jun...
7 Most Promising Penny Stocks to Achieve Your Multibagger Dreams
Penny stocks are a great entry into the market. Here are seven that have the potential to provide quick returns with their strong catalysts.
Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the ...
FREMONT, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has been granted an additional patent cove...
3 Biopharma Penny Stocks That Could be Millionaire Makers
These three biotech penny stocks all have developed drugs that have shown strong indications of success. The post 3 Biopharma Penny Stocks That Could be Millionaire Makers appeared first on InvestorPlace.
ZSAN Stock: Why Zosano Pharma Is Racing Higher Today
ZSAN stock is zooming higher on Thursday after Zosano Pharma shared positive data on its proprietary migraine treatment. The post ZSAN Stock: Why Zosano Pharma Is Racing Higher Today appeared first on I...
Zosano Stock Surges After New Study Shows Qtrypta's Potential As Long-Term Treatment Option For Migraine
Nano-cap Zosano Pharma Corporation (NASDAQ: ZSAN) has announced that long-term data for Qtrypta, as an acute treatment of migraine, published in The Journal of Headache and Pain. The tolerability and ef...
Zosano Pharma Announces Publication of Clinical Data Regarding the Long-term use of Qtrypta™ for the Treatment of Acu...
FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that an article titled, “Long Term Safety, Tolerabi...
Zosano Appoints Industry Veteran, Kathy McGee, to its Board of Directors
FREMONT, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the appointment of Kathy McGee, an accomplished bio...
Zosano Pharma Reports First Quarter 2021 Financial Results
FREMONT, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March...
3 Penny Stocks to Watch During the Last Week of April
As April comes to an end, are these 3 penny stocks worth watching? The post 3 Penny Stocks to Watch During the Last Week of April appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results
FREMONT, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year...
Zosano Pharma to Present at the H.C. Wainwright Global Life Sciences Conference
FREMONT, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, S...
Zosano Pharma Confirms NDA Resubmission Strategy Following Type A Meeting Minutes from FDA
FREMONT, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has received the official Type A ...
ZSAN Stock: 9 Things to Know About Zosano Pharma as Shares Fly Higher
Zosano Pharma (ZSAN) stock is flying high on Tuesday with heavy trading despite there being a lack of news about the company. The post ZSAN Stock: 9 Things to Know About Zosano Pharma as Shares Fly High...
Zosano Pharma Presents Early-Onset of Action Data for Qtrypta™ in Acute Treatment of Migraines
FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that early onset of action data for Qtrypta™, Zosa...